What it is
Regulatory status: dietary supplement or food-derived compound; not approved to prevent or treat cancer
Mechanism evidence: human
Sulforaphane activates cellular stress-response pathways including Nrf2 in human biomarker studies. Conversion from glucoraphanin varies greatly with myrosinase activity, gut microbes and product formulation.
What it is, why people use it, the evidence, and what to know before trying it.
Regulatory status: dietary supplement or food-derived compound; not approved to prevent or treat cancer
Mechanism evidence: human
Human trials show biomarker effects, but clinical outcomes remain inconsistent and formulation-dependent. It should not be presented as a proven cancer-prevention or detoxification treatment.
Confidence: weak
Known side effects, interactions and use limits from reviewed sources.
Gastrointestinal effects are the most common short-term issue. Thyroid disease, pregnancy, cancer treatment and medicines warrant clinical review, and product potency cannot be inferred from broccoli weight alone.
This review does not automatically apply to:
Public protocols that include Sulforaphane. Open one to see the full context and source.
Amount and timing patterns reported in public protocols; these are observations, not instructions. Private and hidden usage is excluded.
Brand variants reported in public protocols. Private entries are excluded, and inclusion is not an endorsement.
Continue into interventions that appear alongside this one.